KE3086A - Pyrazolo(3,4,6)quinolines - Google Patents

Pyrazolo(3,4,6)quinolines

Info

Publication number
KE3086A
KE3086A KE3086A KE308680A KE3086A KE 3086 A KE3086 A KE 3086A KE 3086 A KE3086 A KE 3086A KE 308680 A KE308680 A KE 308680A KE 3086 A KE3086 A KE 3086A
Authority
KE
Kenya
Prior art keywords
quinolines
pyrazolo
Prior art date
Application number
KE3086A
Other languages
English (en)
Inventor
R R Crenshaw
P Siminoff
G M Luke
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of KE3086A publication Critical patent/KE3086A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/38Nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/041,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/121,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/141,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/201,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in position 4
    • C07D265/22Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Fodder In General (AREA)
KE3086A 1973-10-01 1980-09-27 Pyrazolo(3,4,6)quinolines KE3086A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/402,657 US4013665A (en) 1973-10-01 1973-10-01 Antiviral, substituted 1,3-dimethyl-1h-pyrazolo(3,4b)quinolines

Publications (1)

Publication Number Publication Date
KE3086A true KE3086A (en) 1980-11-07

Family

ID=23592812

Family Applications (1)

Application Number Title Priority Date Filing Date
KE3086A KE3086A (en) 1973-10-01 1980-09-27 Pyrazolo(3,4,6)quinolines

Country Status (19)

Country Link
US (1) US4013665A (fi)
JP (1) JPS582948B2 (fi)
BE (1) BE820400A (fi)
CA (1) CA1032538A (fi)
CH (3) CH621552A5 (fi)
CY (1) CY1087A (fi)
DE (1) DE2446821A1 (fi)
DK (1) DK516274A (fi)
ES (1) ES430554A1 (fi)
FI (1) FI57414C (fi)
FR (1) FR2245369B1 (fi)
GB (1) GB1488692A (fi)
HK (1) HK59380A (fi)
KE (1) KE3086A (fi)
MY (1) MY8100219A (fi)
NL (1) NL7412959A (fi)
NO (1) NO143223C (fi)
SE (1) SE419760B (fi)
ZA (1) ZA746138B (fi)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA848968B (en) * 1983-11-18 1986-06-25 Riker Laboratories Inc 1h-imidazo(4,5-c)quinolines and 1h-imidazo(4,5-c)quinolin-4-amines
IL73534A (en) * 1983-11-18 1990-12-23 Riker Laboratories Inc 1h-imidazo(4,5-c)quinoline-4-amines,their preparation and pharmaceutical compositions containing certain such compounds
WO1992018488A1 (fr) * 1991-04-10 1992-10-29 Japan Tobacco Inc. Nouveau derive d'oxazinone
US5608067A (en) * 1993-12-09 1997-03-04 Afonso; Adriano 4-substituted pyrazoloquinoline derivatives
US5506236A (en) * 1994-04-28 1996-04-09 Schering Corporation 4-substituted pyrazoloquinoline derivatives
US5786480A (en) * 1994-04-28 1998-07-28 Schering Corporation 4-substituted pyrazoloquinoline derivatives
US5614530A (en) * 1995-03-10 1997-03-25 Sterling Winthrop Inc. Substituted N-arylmethyl and heterocyclmethyl-1H-pyrazolo[3,4-b]quinolin-4-amines and compositions and methods of use thereof
US6008226A (en) * 1995-03-10 1999-12-28 Sanofi-Synthelabo Substituted N-arylmethyl and heterocylylmethyl-1H-pyrazolo[3,4-b]quinolin-4-amines and compositions and methods of use thereof
US5488055A (en) * 1995-03-10 1996-01-30 Sanofi Winthrop Inc. Substituted N-cycloalkylmethyl-1H-pyrazolo(3,4-b)quinolin-4 amines and compositions and methods of use thereof
CA2468015A1 (en) * 2001-11-27 2003-06-05 Merck & Co., Inc. 2-aminoquinoline compounds
CA2468159A1 (en) * 2001-11-27 2003-06-05 Merck & Co., Inc. 4-aminoquinoline compounds
US8080560B2 (en) * 2004-12-17 2011-12-20 3M Innovative Properties Company Immune response modifier formulations containing oleic acid and methods
US8889154B2 (en) 2005-09-15 2014-11-18 Medicis Pharmaceutical Corporation Packaging for 1-(2-methylpropyl)-1H-imidazo[4,5-c] quinolin-4-amine-containing formulation
NO343857B1 (no) * 2006-07-18 2019-06-24 Meda Ab Immunresponsmodifiserende skumformuleringer
CA2659733A1 (en) * 2006-07-31 2008-02-07 3M Innovative Properties Company Sterilized topical compositions of 1-(2-methylpropyl)-1h-imidazo[4,5-c]quinolin-4-amine
WO2010062559A1 (en) * 2008-10-28 2010-06-03 Schering Corporation Substituted pyrazoloquinolines and derivatives thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1445719A1 (de) * 1961-03-21 1969-01-09 Bayer Ag Verfahren zur Herstellung von 4-Chlor- oder 4-Brom-pyrazolo[3,4-]chinolinen
DE1152421B (de) * 1961-03-21 1963-08-08 Bayer Ag Verfahren zur Herstellung von 4-Hydroxy-pyrazolo[3, 4-b]chinolinen
DE1186867B (de) * 1961-05-03 1965-02-11 Bayer Ag Verfahren zur Herstellung von heterocyclischen Verbindungen
DE1222885B (de) * 1962-05-25 1966-08-18 Bayer Ag Optische Aufhellungsmittel
US3600393A (en) * 1969-03-03 1971-08-17 Aldrich Chem Co Inc Dialkylamino alkylamino pyrazolo (3,4b) quinolines
JPS4826797A (fi) * 1971-08-07 1973-04-09
US3790576A (en) * 1972-03-20 1974-02-05 Parke Davis & Co 9 substituted 4,9-dihydro-1,3,4,4-tetraalkyl-1h-pyrazolo(3,4-b)quinolines

Also Published As

Publication number Publication date
NL7412959A (nl) 1975-04-03
CH619712A5 (fi) 1980-10-15
JPS5059396A (fi) 1975-05-22
ES430554A1 (es) 1977-07-01
FI57414C (fi) 1980-08-11
CH622793A5 (fi) 1981-04-30
CY1087A (en) 1980-12-27
MY8100219A (en) 1981-12-31
HK59380A (en) 1980-10-31
NO143223B (no) 1980-09-22
DK516274A (fi) 1975-06-30
NO143223C (no) 1981-01-02
AU7379874A (en) 1976-04-01
SE419760B (sv) 1981-08-24
CA1032538A (en) 1978-06-06
FI281574A (fi) 1975-04-02
SE7412275L (fi) 1975-04-02
GB1488692A (en) 1977-10-12
DE2446821A1 (de) 1975-04-10
USB402657I5 (fi) 1976-04-06
BE820400A (fr) 1975-03-26
FI57414B (fi) 1980-04-30
JPS582948B2 (ja) 1983-01-19
FR2245369A1 (fi) 1975-04-25
US4013665A (en) 1977-03-22
FR2245369B1 (fi) 1978-07-28
ZA746138B (en) 1975-10-29
NO743528L (fi) 1975-04-28
CH621552A5 (fi) 1981-02-13

Similar Documents

Publication Publication Date Title
PH11009A (en) Triazolyl-o,n-acetals
AU6877174A (en) Quinolines
IL46162A (en) 2-acyl-4-oxo-hexahydro-4h-pyrazino-(2,1- )-isoquinolines
KE3086A (en) Pyrazolo(3,4,6)quinolines
IL45114A (en) 3-substituted 5,5-diphenylhydantoins
MY8100330A (en) 1,3-diketo-1,2,3,4-tetrahydrosoquinolines
IL45259A0 (en) 1,3-oxygenated 8alpha-oestratrienes
AU7321974A (en) 8-hydroxyquinolines
ZA744478B (en) 1,3-oxygenated 8alpha-oestratrienes
GB1482285A (en) 1,3-oxygenated 8alpha-oestratrienes
AU6850574A (en) 1,3-benzodioxole-2-carboxylic acid
AU7278974A (en) 2,3-dihydrobenzofuranyl-7-n-methylcarbamates
PH13669A (en) 6-nor-6-isopropyl-9,10-dihydro-2'beta-methyl-5'alpha-benzyl-ergopetine
ZA744364B (en) 4,3-dihydro-2h-naphthalin-1-one-5-oxypropyl-piperazine derivatives
AU6558474A (en) 7-alkyl-delta 3,5-steroids
ZA743304B (en) 17beta-hydroxy-16,16-dimethylestr-4-en-3-one
ZA741268B (en) Imidazo (4,5-f) quinolin-9-ols
IE40060L (en) 1,5- and 1,8-dinitroanthraquinones
AU6776774A (en) 2,3-dhydro-benzofurans
AU7271274A (en) 1,2-oxaphospholanes
ZA747367B (en) 3,3a-dihydro-2h,9h-isoxazolo(3,2-b) (1,3) benzoxazin-9-ones
CA1031335A (en) 6,7,8,9-tetrahydro-1h-pyrazolo (3,4-b) (1,5) diazocines
AU6593074A (en) 1, 4-dihydro-2-h-isoquinoline
PH10500A (en) 7h-indolizino(5,6,7-ij)isoquinoline derivatives
CA1024140A (en) 6-anilino-1,4,5-trihydroxyanthraquinones